Responses
Regular and young investigator award abstracts
Clinical trials in progress
338 Emerging insights on the association of tumor molecular phenotype with clinical benefit in metastatic colorectal cancer (mCRC) subjects treated with AB928 + modified FOLFOX-6 (mFOLFOX-6)
Compose a Response to This Article
Other responses
No responses have been published for this article.
